Study to Determine the Dose, the Safety and Effectiveness of a New Drug, Modified Release rhTSH, in Patients With Multinodular Goiter

NCT00454220 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

96

Enrollment

INDUSTRY

Sponsor class

Conditions

Multinodular Goiter

Interventions

OTHER: Placebo
DRUG: MRrhTSH
DRUG: MRrhTSH

Sponsor

Genzyme, a Sanofi Company